Basic information Source Reactivity Background References Safety Supplier Related

Col11a1 Antibody

Basic information Source Reactivity Background References Safety Supplier Related

Col11a1 Antibody Basic information

Product Name:
Col11a1 Antibody
Synonyms:
  • Col11a1 Antibody
MW:
0
Mol File:
Mol File
More
Less

Col11a1 Antibody Usage And Synthesis

Source

Rabbit

Reactivity

Human

Background

The Extracellular Matrix is a complex network of macromolecules that provides structural tissue support to cells in the basement membrane and interstitial matrix. It is composed of many molecules, including proteins, glycoproteins, proteoglycans, and polysaccharides. One of the major proteins that comprise the ECM, and the human body, is collagen. Collagens are a large family of proteins. They are trimeric molecules composed of three alpha polypeptide chains that form a triple helix structure that is characteristic of all collagens. The large family of collagens is divided into three subgroups: the fibrillar collagens, the non-fibril forming collagens, and the fibril-associated collagens. These subgroups differ in their structure and supramolecular assembly.Collagen11A1 is a minor fibrillar collagen that is not normally expressed at high levels in most normal tissues with the exception of cartilage, where it is expressed in high levels, and some other tissues/ organs, where it is expressed at a lower level. However, it has been reported that the expression of this molecule is correlated with advanced tumorigenic disease through meta analysis of data from multiple cancers, including ovarian, colon, breast, and lung. Additionally, it has also been associated with epithelial-mesenchymal transition and metastasis. Cancer associated fibroblasts are typically the most abundant cell type in the stroma of many solid tumors. They are thought to contribute to ECM stiffness, which is ultimately thought to contribute to tumor growth and resistance to chemotherapeutic intervention. COL11A1 has been found to be elevated in CAFs and may contribute to chemotherapy resistance.

References

[1] Barkan, D. et al. (2010) Eur J Cancer 46, 1181-8.
[2] Hynes, R.O. (2009) Science 326, 1216-9.
[3] Ricard-Blum, S. (2011) Cold Spring Harb Perspect Biol 3, a004978.
[4] Yoshioka, H. et al. (1995) Dev Dyn 204, 41-7.
[5] Kim, H. et al. (2010) BMC Med Genomics 3, 51.
[6] Cheon, D.J. et al. (2014) Clin Cancer Res 20, 711-23.
[7] Fuentes-Martínez, N. et al. (2015) Histol Histopathol 30, 87-93.
[8] Sok, J.C. et al. (2013) Br J Cancer 109, 3049-56.

Col11a1 AntibodySupplier

Hubei Ipodix Biotechnology Co.,Ltd.
Tel
18007124176 19384116026
Email
2706668885@qq.com
CUSABIO TECHNOLOGY LLC
Tel
027-87196173
Email
cusabio@163.com
Shanghai Qierqi Biotech Co., Ltd.
Tel
027-19371278702 18008634902
Email
ruihening88@163.com
GeneTex, Inc.
Tel
0755-26755892 1-949-553-1900
Email
international@genetex.com
Biosynth Ltd
Tel
18886812933
Email
sales@biosynth.com